Comparison of nonlinear mixed-effect and non-parametric expectation maximisation modelling for Bayesian estimation of carboplatin clearance in children

European Journal of Clinical Pharmacology

Volumn 57, Issue 4, 2001, Pages 297-303

  Patoux, A ^f   Bleyzac, N ^b   Boddy, A V ^c   Doz, F ^d   Rubie, H ^a   Bastian, G ^e   Maire, P ^b   Canal, P ^a   Chatelut, E ^f  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b Hopital A Charial   (France)

^c Cancer Research Unit   (United Kingdom)

^d INSTITUT CURIE   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f NONE   (France)

Author keywords

Carboplatin; Individual dosing; Population pharmacokinetics

Indexed keywords

CARBOPLATIN;

ACCURACY; ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BAYES THEOREM; CHILD; COMPARATIVE STUDY; DOSE RESPONSE; DRUG CLEARANCE; DRUG MONITORING; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; NONLINEAR SYSTEM; PRIORITY JOURNAL;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BAYES THEOREM; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MODELS, THEORETICAL; NONLINEAR DYNAMICS; STATISTICS, NONPARAMETRIC;

EID: 0034905408     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280100306     Document Type: Article

References (25)

1. Application of the area under the curve of carboplatin in predicting toxicity and efficacy
2. Clinical pharmacokinetics and dose optimisation of carboplatin
3. Phase I of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors
4. Carboplatin pharmacokinetics in children: The development of a pediatric dosing formula
5. Validation of pharmacologically-guided dosing of carboplatin in paediatric patients
6. Real-time monitoring of carboplatin pharmacokinetics in paediatric patients receiving high-dose chemotherapy
7. Clinical pharmacokinetics of carboplatin in children
8. Comparison of methods for the estimation of carboplatine pharmacokinetics in paediatric cancer patients
9. A limited-sampling method for evaluation of the area under the curve of ultrafiltrable carboplatin in children
10. Methodology of population pharmacokinetics
11. Non parametric EM algorithms for estimating prior distributions
12. Population pharmacokinetics of carboplatin in children
13. Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry
14. A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage
15. Some suggestions for measuring predictive performance
16. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine
17. Prediction of creatinine clearance from serum creatinine
18. Comparison of population pharmacokinetic modeling methods using simulated data: Results from the population modeling workgroup
19. Preliminary results of three methods for population pharmacokinetic analysis (NONMEM, NPML, NPEM) of amikacin in geriatric and general medicine patients
20. Prospective evaluation of ten methods for estimating creatinine clearance in children with varying degrees of renal dysfunction
21. Comparison of methods of estimating creatinine clearance in children
22. Simple estimate of creatinine clearance from plasma creatinine in neonates
23. Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine